Beiersdorf (BEI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
7 Jan, 2026Executive summary
Achieved record net sales of €9.9 billion in 2024, with 6.5% organic growth at group level and 7.5% in the Consumer segment, despite macroeconomic and geopolitical headwinds.
EBIT margin (excluding special factors) improved by 50 basis points to 13.9%, and EBIT reached nearly €1.4 billion, with EPS rising from €3.24 to €4.05.
Outperformed key competitors in organic sales growth, driven by innovation, brand strength, and expansion into new markets.
Continued focus on sustainability, diversity, and inclusion, achieving significant milestones in emissions reduction and gender parity.
Positioned for ongoing success in 2025 and beyond, with a focus on DE&I and climate action.
Financial highlights
Group organic sales growth of 6.5% and nominal growth of 4.3%; Consumer segment organic growth at 7.5%, nominal at 4.9%.
EBIT margin (excluding special factors) increased to 13.9%; profit after tax reached €928 million.
Gross margin improved by 120 basis points, driven by pricing and premiumization, offsetting FX headwinds.
Earnings per share reached €4.05, up from €3.24 in the prior year.
Marketing spend increased to 26.9% of net sales, with 70% digital focus.
Outlook and guidance
2025 group organic sales growth expected in the 4%-6% range; Consumer segment guidance also 4%-6%.
EBIT margin (excluding special factors) projected to be slightly above 2024; Consumer segment margin to improve by 50 basis points.
Tesa segment organic sales growth expected at 1%-3%, with EBIT margin around 16%.
Q1 2025 expected below full-year range due to strong prior-year comparison and China inventory cleanup.
Latest events from Beiersdorf
- Solid 2025 growth driven by Derma, with flat outlook and margin pressure expected in 2026.BEI
Q4 20253 Mar 2026 - 7.1% organic sales growth, margin expansion, and guidance reaffirmed despite market headwinds.BEI
Q2 20242 Feb 2026 - Strong 6.5% organic sales growth led by NIVEA and Derma; guidance for 6–8% reaffirmed.BEI
Q3 202419 Jan 2026 - Q1 2025 organic sales up 3.6%, with Derma and tesa outperformance; guidance reaffirmed.BEI
Q1 202527 Dec 2025 - Organic sales rose 2.0% to €7.5B, led by Derma, as guidance was trimmed amid market slowdown.BEI
Q3 20253 Dec 2025 - Organic sales up 2.1% in H1 2025, with stable margins and strong Derma growth.BEI
Q2 202523 Nov 2025 - Accelerated growth, innovation, and sustainability drive Beiersdorf’s leadership in global skin care.BEI
CMD 2024 Presentation13 Jun 2025